Bill Text: TX SB2350 | 2019-2020 | 86th Legislature | Introduced
Bill Title: Relating to the prohibited administration of certain vaccinations.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2019-03-21 - Referred to Health & Human Services [SB2350 Detail]
Download: Texas-2019-SB2350-Introduced.html
| 86R13084 JG-F | ||
| By: Hall | S.B. No. 2350 | |
|
|
||
|
|
||
| relating to the prohibited administration of certain vaccinations. | ||
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
| SECTION 1. Subchapter A, Chapter 161, Health and Safety | ||
| Code, is amended by adding Section 161.0045 to read as follows: | ||
| Sec. 161.0045. ADMINISTRATION OF CERTAIN VACCINES | ||
| PROHIBITED. A health care provider may administer a vaccine only | ||
| if: | ||
| (1) the study relied on by the United States Food and | ||
| Drug Administration for approval of the vaccine evaluated the | ||
| safety of the vaccine against a control group that received: | ||
| (A) a placebo; or | ||
| (B) another vaccine or other substance approved | ||
| by the United States Food and Drug Administration based on a study | ||
| that evaluated the safety of that vaccine or substance against a | ||
| control group that received a placebo for that study; | ||
| (2) the study relied on by the United States Food and | ||
| Drug Administration for approval of the vaccine evaluated the | ||
| safety of the vaccine for a sufficient time to identify potential | ||
| autoimmune, neurological, or chronic health conditions that may | ||
| arise on or after the first anniversary of the date the vaccine is | ||
| administered; | ||
| (3) the vaccine has been evaluated for the vaccine's | ||
| potential to: | ||
| (A) cause cancer; | ||
| (B) mutate genes; | ||
| (C) affect fertility or cause infertility; and | ||
| (D) cause autism spectrum disorder; | ||
| (4) the department has posted on the department's | ||
| Internet website a disclosure of any known injuries or diseases | ||
| caused by the vaccine and the rate at which the injuries or diseases | ||
| have occurred; and | ||
| (5) the chemical, pharmacological, therapeutic, and | ||
| adverse effects of the vaccine and the rate of injury of the vaccine | ||
| when administered with other vaccines have been studied and | ||
| verified. | ||
| SECTION 2. This Act takes effect September 1, 2019. | ||
